• US: +1 9176726599
  • Login

Syndromic Multiplex Panels Market Status (2017-2021) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2022-2028

Format: PDF | Pages: 298 | Report ID: MRS1182


Report Description

The global Syndromic Multiplex Panels market size is estimated at USD XX billion in 2021, expanding at a CAGR of 7.1% from 2022 to 2028 to reach USD XX billion USD in 2028.

Market Dynamics

Multiple pathogens are diagnosed concurrently using syndromic multiplex testing. Various types of reagents and consumables, as well as devices and accessories, are utilized in syndromic multiplex Panels, which helps to maintain accuracy and deliver quick diagnosis findings. These multiplex tests can quickly detect some illnesses, allowing for quick clinical management decisions. Test panels are multiplex tests that use multiplex technology. Syndromic testing panels are used to identify several disorders that are linked to the same or comparable syndrome type. These panels aid in determining the source of sickness at the time of treatment. Syndromic panels are divided into two categories: gastrointestinal and respiratory.

Syndromic multiplex testing makes use of sophisticated multiplex PCR technology to deliver reliable and quick diagnostic findings. Multiple panels are utilized in syndromic multiplex Panels to do is provide a definitive diagnosis in under an hour. The novel syndromic multiplexes can quickly detect common infections in respiratory specimens, blood, and cerebrospinal fluid. Multiplex panels are linked to shorter turnaround times, less superfluous laboratory tests, faster diagnosis, and more tailored therapy.

Regional Insights

Due to technological improvements and better healthcare, North America is expected to occupy a substantial market share for syndromic multiplex Panels. The existence of research facilities on a large scale in the region also has a good impact on the sales of syndromic multiplex Panels. Due to the increased acceptance of new technologies and the need for improved treatment choices, sales of syndromic multiplex Panels have increased dramatically in Europe. Due to escalating diseases and government programs aimed at raising public awareness about different infections, Asia Pacific occupies a significant proportion of the syndromic multiplex Panels market.

Segment Dynamics

Respiratory syndromes account for the vast majority of the syndromic multiplex Panels market, and this trend is likely to continue during the forecast period. This dominance is mostly due to reasons such as increased demand as a result of the rapid spread of infections, as well as the introduction of new drugs with USFDA approvals in the category that adds to its significant revenue share the worldwide market. Due to the availability of all assets at a single location, hospitals account for the biggest percentage of end-users. Moreover, the market is likely to be fueled by the decrease in overall patient stay in hospitals due to reduced procedural time, low or no uncertainty, and treatment mistakes throughout the forecast period.

Competitive Insights

The market for Syndromic Multiplex Panels is very competitive, with both domestic and foreign players involved. To stay competitive, large corporations engage in strategic mergers and acquisitions, collaborations, and new product launches. Some major businesses are launching new items, while some are selling them and expanding their market share through acquisitions and alliances. Luminex Corporation, BIOMERIEUX SA, Applied BioCode, QIAGEN, and Akonni Biosystems are some of the firms currently leading the industry.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Syndromic Multiplex Panels by product type, syndromes, and regions. In addition, this report introduces the market competition situation among the vendors, and the company profile, besides, market price analysis, and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Qiagen
  • Oxford Nanopore Technologies
  • Operon 
  • Novel Microdevices
  • Nanomix
  • Molbio Diagnostics
  • Mobidiag (Hologic) 
  • Millipore Sigma
  • Mesa Biotech (Thermo Fisher)
  • Luminex Corporation
  • Hologic, Inc.
  • Diagenode Diagnostics
  • BIOMERIEUX SA
  • Applied BioCode
  • Akonni Biosystems
  • Accelerate Diagnostic
  • Abbott Laboratories

Product Type Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Instruments
  • Cartridges
  • Reagents
  • Others

Syndromes Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Respiratory
  • Gastrointestinal
  • Blood
  • Meningitis/Encephalitis
  • Sexually Transmitted Disease
  • Others

End Users Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Hospital Lab
  • Outpatient Lab
  • Point of Care
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Syndromic Multiplex Panels market size is estimated at USD XX billion in 2021, expanding at a CAGR 7.1% from 2022-2028 to reach USD XX billion USD in 2028.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Syndromic Multiplex Panels market size is expanding at a CAGR 7.1% from 2022-2028 to reach USD XX billion USD in 2028.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The market for Syndromic Multiplex Panels is very competitive, with both domestic and foreign players involved. To stay competitive, large corporations engage in strategic mergers and acquisitions, collaborations, and new product launches. Some major businesses are launching new items, while some are selling them and expanding their market share through acquisitions and alliances. Luminex Corporation, BIOMERIEUX SA, Applied BioCode, QIAGEN, and Akonni Biosystems are some of the firms currently leading the industry.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.